Omega Healthcare Investors Inc financial data

Symbol
OHI on NYSE
Industry
Real Estate Investment Trusts
Location
303 International Circle,, Suite 200, Hunt Valley, MD
State of incorporation
MD
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Feb 13, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Debt-to-equity 129 % -16.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 282M shares +14.9%
Common Stock, Shares, Outstanding 279M shares +13.8%
Entity Public Float 8.7B USD +17.6%
Common Stock, Value, Issued 27.9M USD +13.8%
Weighted Average Number of Shares Outstanding, Basic 258M shares +7.33%
Weighted Average Number of Shares Outstanding, Diluted 270M shares +7.99%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 1.05B USD +10.7%
General and Administrative Expense 88M USD +7.97%
Income Tax Expense (Benefit) 10.9M USD +73.6%
Earnings Per Share, Basic 1.57 USD/shares +55.4%
Earnings Per Share, Diluted 1.55 USD/shares +55%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 518M USD +17.1%
Operating Lease, Right-of-Use Asset 28.3M USD -6.22%
Goodwill 644M USD -0.04%
Assets 9.9B USD +8.56%
Liabilities 5.17B USD -3.51%
Accumulated Other Comprehensive Income (Loss), Net of Tax 22.7M USD -22.5%
Retained Earnings (Accumulated Deficit) 4.09B USD +11%
Stockholders' Equity Attributable to Parent 4.54B USD +26.9%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 4.73B USD +25.7%
Liabilities and Equity 9.9B USD +8.56%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 151M USD +36%
Net Cash Provided by (Used in) Financing Activities -186M USD -11.8%
Net Cash Provided by (Used in) Investing Activities -47.5M USD -1886%
Common Stock, Shares Authorized 350M shares 0%
Common Stock, Shares, Issued 279M shares +13.8%
Common Stock, Par or Stated Value Per Share 0.1 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -81.7M USD -56.7%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 549M USD +23.4%
Interest Paid, Excluding Capitalized Interest, Operating Activities 58.4M USD -4.95%
Deferred Tax Assets, Valuation Allowance 1.93M USD -4.89%
Operating Lease, Liability 30.3M USD -4.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 400M USD +59.1%
Deferred Tax Assets, Operating Loss Carryforwards 2.05M USD -1.49%
Preferred Stock, Shares Issued 0 shares
Current Income Tax Expense (Benefit) 10.9M USD +73%
Preferred Stock, Shares Authorized 20M shares 0%
Additional Paid in Capital 7.92B USD +18.7%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 305M USD -4.7%
Share-based Payment Arrangement, Expense 36.7M USD +4.56%
Preferred Stock, Par or Stated Value Per Share 1 USD/shares 0%